Varsity Blue’s Clues
-
FEEDI have real suspicions about this information: the notion that the net
cost is about $13,000 a year is just plain wrong. It’s approaching $100,000
a ye...
2022-06-24
Profit Taking in Biotech
After leading the rally, biotech is selling off today. Potentially a side of running out steam, but also a sign of natural profitaking as sectors such as communication services (XLC) take the mantle.
As long as biotech is an outlier, I think this is healthy rally action. It will be concerning if the rest of market sells off and biotech continues falling.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment